These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8791040)

  • 1. Interregional correlation of cerebral glucose metabolism in unmedicated schizophrenia.
    Biver F; Goldman S; De Maertelaer V; Luxen A; Mendlewicz J; Lotstra F
    Eur Neuropsychopharmacol; 1996 May; 6(2):141-7. PubMed ID: 8791040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients.
    Siegel BV; Buchsbaum MS; Bunney WE; Gottschalk LA; Haier RJ; Lohr JB; Lottenberg S; Najafi A; Nuechterlein KH; Potkin SG
    Am J Psychiatry; 1993 Sep; 150(9):1325-36. PubMed ID: 8352343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered frontostriatal relationship in unmedicated schizophrenic patients.
    Biver F; Goldman S; Luxen A; Delvenne V; De Maertelaer V; De La Fuente J; Mendlewicz J; Lotstra F
    Psychiatry Res; 1995 Sep; 61(3):161-71. PubMed ID: 8545500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional brain function in schizophrenia. I. A positron emission tomography study.
    Gur RE; Resnick SM; Alavi A; Gur RC; Caroff S; Dann R; Silver FL; Saykin AJ; Chawluk JB; Kushner M
    Arch Gen Psychiatry; 1987 Feb; 44(2):119-25. PubMed ID: 3492982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age differences in intercorrelations between regional cerebral metabolic rates for glucose.
    Horwitz B; Duara R; Rapoport SI
    Ann Neurol; 1986 Jan; 19(1):60-7. PubMed ID: 3484930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [No hypofrontality in schizophrenia demonstrated by positron emission tomography].
    Biver F; Delvenne V; Goldman S; Luxen A; De Maertelaer V; Lotstra F; Mendlewicz J
    Acta Psychiatr Belg; 1992; 92(5):261-78. PubMed ID: 1345405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of PET measurement of local brain glucose metabolism and CAT measurement of brain atrophy in chronic schizophrenia and depression.
    Kling AS; Metter EJ; Riege WH; Kuhl DE
    Am J Psychiatry; 1986 Feb; 143(2):175-80. PubMed ID: 3946650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cerebral glucose metabolism in schizophrenia. Studies using positron-emission tomography].
    M'Rabet N; Lotstra F; Goldman S; Delvenne V; Mendlewicz J
    Acta Psychiatr Belg; 1991; 91(6):311-26. PubMed ID: 1670424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography.
    Wolkin A; Jaeger J; Brodie JD; Wolf AP; Fowler J; Rotrosen J; Gomez-Mont F; Cancro R
    Am J Psychiatry; 1985 May; 142(5):564-71. PubMed ID: 3872603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional brain glucose metabolism in chronic schizophrenia. A positron emission transaxial tomographic study.
    Farkas T; Wolf AP; Jaeger J; Brodie JD; Christman DR; Fowler JS
    Arch Gen Psychiatry; 1984 Mar; 41(3):293-300. PubMed ID: 6608333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The current status of PET scanning with respect to schizophrenia.
    Sedvall G
    Neuropsychopharmacology; 1992 Aug; 7(1):41-54. PubMed ID: 1388021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reproducibility of cerebral glucose utilization measured by PET and the [18F]-2-fluoro-2-deoxy-d-glucose method in resting, healthy human subjects.
    Maquet P; Dive D; Salmon E; von Frenckel R; Franck G
    Eur J Nucl Med; 1990; 16(4-6):267-73. PubMed ID: 2351175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial correlation coefficients approximate the real intrasubject correlation pattern in the analysis of interregional relations of cerebral metabolic activity.
    Horwitz B; Rapoport SI
    J Nucl Med; 1988 Mar; 29(3):392-9. PubMed ID: 3258028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vulnerability to tardive dyskinesia development in schizophrenia: an FDG-PET study of cerebral metabolism.
    Szymanski S; Gur RC; Gallacher F; Mozley LH; Gur RE
    Neuropsychopharmacology; 1996 Dec; 15(6):567-75. PubMed ID: 8946431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Independent thallium-201 accumulation and fluorine-18-fluorodeoxyglucose metabolism in glioma.
    Oriuchi N; Tomiyoshi K; Inoue T; Ahmad K; Sarwar M; Tokunaga M; Suzuki H; Watanabe N; Hirano T; Horikoshi S; Shibasaki T; Tamura M; Endo K
    J Nucl Med; 1996 Mar; 37(3):457-62. PubMed ID: 8772644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased anterior cingulate gyrus metabolic rate in schizophrenia.
    Haznedar MM; Buchsbaum MS; Luu C; Hazlett EA; Siegel BV; Lohr J; Wu J; Haier RJ; Bunney WE
    Am J Psychiatry; 1997 May; 154(5):682-4. PubMed ID: 9137127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The brain metabolic patterns of clozapine- and fluphenazine-treated patients with schizophrenia during a continuous performance task.
    Cohen RM; Nordahl TE; Semple WE; Andreason P; Litman RE; Pickar D
    Arch Gen Psychiatry; 1997 May; 54(5):481-6. PubMed ID: 9152102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Regional cerebral glucose metabolism associated with ataxic gait--an FDG-PET activation study in patients with olivopontocerebellar atrophy].
    Mishina M; Senda M; Ohyama M; Ishii K; Kitamura S; Terashi A
    Rinsho Shinkeigaku; 1995 Nov; 35(11):1199-204. PubMed ID: 8720328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal lobe metabolic differences in medication-free outpatients with schizophrenia via the PET-600.
    Nordahl TE; Kusubov N; Carter C; Salamat S; Cummings AM; O'Shora-Celaya L; Eberling J; Robertson L; Huesman RH; Jagust W; Budinger TF
    Neuropsychopharmacology; 1996 Dec; 15(6):541-54. PubMed ID: 8946428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for common alterations in cerebral glucose metabolism in major affective disorders and schizophrenia.
    Cohen RM; Semple WE; Gross M; Nordahl TE; King AC; Pickar D; Post RM
    Neuropsychopharmacology; 1989 Dec; 2(4):241-54. PubMed ID: 2610821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.